Project Details
Projekt Print View

Goblet cells and the mucus barrier in intestinal inflammation

Subject Area Pediatric and Adolescent Medicine
Gastroenterology
Term from 2022 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 501883972
 
Final Report Year 2025

Final Report Abstract

Analysis of rare human monogenic disease models can help to understand the pathophysiological pathways that control barrier function and immunity. Biallelic Anterior gradient 2 (AGR2) loss-of-function variants in humans cause infantile-onset inflammatory bowel disease, alongside histological changes of the gastric epithelium and a depletion of goblet cell. The underlying mechanisms of AGR2 defects on epithelial development and function are not yet well understood. We show that AGR2-deficiency represents a genetic model of precancerous intestinal metaplastic lesions and goblet cell dysfunction with high endoplasmic reticulum (ER)-stress. An apparent depletion of goblet cells was found in AGR2-deficiency and ulcerative colitis, but this is a histological artefact, representing a reduction of stored mucins. This study highlights the role of AGR2-deficiency as a relevant protein in epithelial cell differentiation causing the development of metaplastic enterocytes in the stomach, while affecting goblet cell function in the colon. Histological goblet cell depletion in AGR2-deficiency is caused by a dysfunction of mucin stores in goblet cells. Similarly in ulcerative colitis, an apparent goblet cell “depletion” is a misrepresentation since single-cell analysis showed maintained goblet cell numbers with high ER-stress. The inflammatory consequences of AGR2-deficiency highlight the relevance of goblet cell ER-stress and mucus production as a pathogenic mechanism for intestinal inflammation.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung